⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19773657 | 0.81 | — | — | |
| SCHEMBL18723464 | 0.75 | — | — | |
| SCHEMBL21508639 | 0.74 | — | — | |
| SCHEMBL18723423 | 0.72 | — | — | |
| SCHEMBL14114721 | 0.72 | — | — | |
| SCHEMBL10326155 | 0.67 | — | — | |
| SCHEMBL903274 | 0.67 | — | — | |
| SCHEMBL14607883 | 0.67 | — | — | |
| SCHEMBL21508644 | 0.66 | — | — | |
| SCHEMBL20643284 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024044570-A1 | COMPOUNDS AND METHODS FOR MODULATING HER2 | IAMBIC THERAPEUTICS, INC. (US) | 2024-02-29 | — | — | WO | disclosed |
| EP-3397629-B1 | METALLOENZYME INHIBITOR COMPOUNDS | NQP 1598 LTD (KY) | 2023-04-19 | — | — | EP | disclosed |
| US-10000496-B2 | Compositions useful for treating disorders related to kit and PDGFR | BLUEPRINT MEDICINES CORPORATION (US) | 2018-06-19 | — | — | US | disclosed |
| EP-3269713-A1 | PIPERIDINE DERIVATIVES AS NK1 ANTAGONISTS | OPKO Health, Inc. (US) | 2018-01-17 | — | — | EP | disclosed |
| EP-2522664-B1 | Piperidine derivatives as NK1 antagonists | OPKO HEALTH INC (US) | 2017-04-12 | — | — | EP | disclosed |
| US-20170022206-A1 | COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT AND PDFGR | BLUEPRINT MEDICINES CORPORATION | 2017-01-26 | — | — | US | disclosed |